HOME >> BIOLOGY >> NEWS
Growth hormone may stimulate production of T cells to boost body's ability to fight HIV

BARCELONA - Growth hormone may stimulate the production of T cells in HIV-infected patients, research at the Gladstone Institute of Virology and Immunology shows. T cells are the immune system cells that HIV attacks and destroys, leaving patients without defenses against the opportunistic infections of AIDS.

Laura Napolitano, MD, lead investigator of the study, presented the research on July 11 at the 14th International AIDS Conference here in Barcelona. Napolitano is a staff research investigator at Gladstone and UCSF assistant professor of medicine.

"Finding a way to stimulate the thymus to produce T cells would help HIV-infected patients to preserve and restore their embattled immune systems," Napolitano said. This study is the first to show that human thymic function can be significantly enhanced by growth hormone therapy to produce new T cells.

Results of the study were published in the May issue of the journal AIDS.

In the study, the researchers gave five HIV-infected male patients daily doses of growth hormone. After six months, the size of the thymus and the number of new T cells circulating in the blood increased significantly.

"The degree of change in the thymus was remarkable," Napolitano said. "Over the past five years, we have studied thymic function in more than four dozen similar patients who did not receive growth hormone, and we have never seen such striking changes in the thymus."

However, growth hormone therapy is not yet ready to be prescribed to stimulate immune function in HIV-infected patients. The study was small, and two of the five patients in the study experienced adverse effects of growth hormone therapy. Potential side effects include the development of diabetes, bone pain, swelling of the arms and legs, abnormal bone growth and carpal tunnel syndrome.

Additionally, this preliminary study was limited in its scope and was not designed to examine whether growth hormone actually improv
'"/>

Contact: Laura Lane
llane@gladstone.ucsf.edu
415-695-3833
University of California - San Francisco
11-Jul-2002


Page: 1 2

Related biology news :

1. Growth hormone and IBD: Reduction of intestinal inflammation, promotion of growth
2. Growth study of wild chimpanzees challenges assumptions about early humans
3. Growth hormone activates gene involved in healing damaged tissue
4. Growth factor shows promise in Parkinsons patients
5. Growth hormone could make farm fish bigger, faster to market
6. Growth hormone may boost production of disease-fighting cells in elderly
7. Growth factor receptor signaling critical to intestinal tumor development, studies show
8. Growth factor may determine who grows new blood vessels that protect against heart attacks
9. Growth hormone involved in diabetic kidney disease, study finds
10. Report: High Carbon Dioxide Boosts Duke Forest Growth By 25 Percent
11. UC Berkeley Conference On Population Growth And The Environment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: